Although detail mechanisms and specific roles of these proteins in tumor progression and metastasis remain to be further characterized in the future, identification of CNOT2/9 and SHMT1 as strong indicators for prognosis and progression in TETs represents a significant advance in discovering novel prognostic biomarker of the TETs by proteomic approaches. The gene discussed is SHMT1; the disease is neoplasm.